Show simple item record

dc.contributor.authorNorman, Jane E
dc.contributor.authorMackenzie, Fiona
dc.contributor.authorOwen, Philip
dc.contributor.authorMactier, Helen
dc.contributor.authorHanretty, Kevin
dc.contributor.authorCooper, Sarah
dc.contributor.authorCalder, Andrew
dc.contributor.authorMires, Gary
dc.contributor.authorDanielian, Peter
dc.contributor.authorSturgiss, Stephen
dc.contributor.authorMacLennan, Graeme
dc.contributor.authorTydeman, Graham
dc.contributor.authorThornton, Steven
dc.contributor.authorMartin, Bill
dc.contributor.authorThornton, James G
dc.contributor.authorNeilson, James P
dc.contributor.authorNorrie, John
dc.date.accessioned2013-02-12T13:50:00Z
dc.date.available2013-02-12T13:50:00Z
dc.date.issued2009-06-13
dc.identifier.citationNorman , J E , Mackenzie , F , Owen , P , Mactier , H , Hanretty , K , Cooper , S , Calder , A , Mires , G , Danielian , P , Sturgiss , S , MacLennan , G , Tydeman , G , Thornton , S , Martin , B , Thornton , J G , Neilson , J P & Norrie , J 2009 , ' Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT) : a randomised, double-blind, placebo-controlled study and meta-analysis ' , The Lancet , vol. 373 , no. 9680 , pp. 2034-2040 . https://doi.org/10.1016/S0140-6736(09)60947-8en
dc.identifier.otherPURE: 13273986
dc.identifier.otherPURE UUID: 84d8f3fe-bf58-4b16-be6c-7ee167240f72
dc.identifier.otherPubMed: 19523680
dc.identifier.otherScopus: 66649092312
dc.identifier.otherORCID: /0000-0002-1039-5646/work/98038626
dc.identifier.urihttp://hdl.handle.net/2164/2644
dc.format.extent7
dc.language.isoeng
dc.relation.ispartofThe Lanceten
dc.rightsNorman, JE, Mackenzie, F, Owen, P, Mactier, H, Hanretty, K, Cooper, S, Calder, A, Mires, G, Danielian, P, Sturgiss, S, MacLennan, GS, Tydeman, G, Thornton, S, Martin, B, Thornton, JG, Neilson, JP & Norrie, JDT 2009, 'Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis' Lancet, vol 373, no. 9680, pp. 2034-2040.Copyright © 2009 Elsevier Ltd. All rights reserved. DOI: 10.1016/S0140-6736(09)60947-8en
dc.subjectadministration, intravaginalen
dc.subjectadolescenten
dc.subjectadulten
dc.subjectdelivery, obstetricen
dc.subjectdouble-blind methoden
dc.subjectfemaleen
dc.subjectfetal deathen
dc.subjectfollow-up studiesen
dc.subjectgelsen
dc.subjectGreat Britainen
dc.subjecthumansen
dc.subjectlikelihood functionsen
dc.subjectlinear modelsen
dc.subjectlogistic modelsen
dc.subjectmiddle ageden
dc.subjectpatient selectionen
dc.subjectpregnancyen
dc.subjectpregnancy outcomeen
dc.subjectpregnancy, high-risken
dc.subjectpregnancy, multipleen
dc.subjectpremature birthen
dc.subjectprogesteroneen
dc.subjectprogestinsen
dc.subjecttreatment failureen
dc.subjecttwinsen
dc.subjectyoung adulten
dc.subjectRG Gynecology and obstetricsen
dc.subject.lccRGen
dc.titleProgesterone for the prevention of preterm birth in twin pregnancy (STOPPIT) : a randomised, double-blind, placebo-controlled study and meta-analysisen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1016/S0140-6736(09)60947-8
dc.identifier.vol373en
dc.identifier.iss9680en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record